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Background: To evaluate the utility of the recently introduced SOLAR score (sonography of large joints in
Rheumatology), which has been validated in RA patients, in a cohort of patients with Psoriatic Arthritis (PsA) and
Ankylosing Spondylitis (AS) presenting with involvement of large peripheral joints.
Methods: The recently established SOLAR score has been designed to determine the degree of inflammation in
the shoulder, the elbow, the hip and the knee joint in patients suffering from RA. Since large joints are frequently
involved in PsA and AS, synovitis and synovial vascularity were scored semiquantitatively (grade 0–3) by grey scale
(GSUS) and power Doppler ultrasound (PDUS) utilizing the validated scoring system. Each joint was scanned from
different angles, the knee joint for example was divided into four areas to score for synovitis: the suprapatellar
longitudinal, the medial longitudinal, the lateral longitudinal, and the posterior region. Each area was scored from
0–3, so a maximum score of 12 could be achieved. PsA and AS patients presenting with peripheral joint disease
involving large joints were examined at baseline, 3 and 6 months after initiation of local or systemic therapy
(DMARDs/Biologics). For evaluation of the inflammatory status, the erythrocyte sedimentation rate (ESR) was
determined.
Results: A cohort of 126 patients were enclosed, and 83 of these were followed for 6 months. At baseline before
modification of the therapy, patients received DMARDs (n = 83), DMARDs plus biologics (n = 30), or biologic
monotherapy (n = 29). Following intervention, all US scores demonstrated a marked improvement. The GSUS and
the PDUS scores for all joint areas, except the PDUS score of the hip, exhibited a significant improvement (p < 0.05),
while the GSUS of the knee showed even a highly significant (p < 0.001) change. The ESR displayed a significant
decrease from 27 to 19 mm (p < 0.002) representing good treatment response.
Conclusion: The SOLAR score, which has been recently introduced for RA patients, is a very suitable instrument for
the qualitative and quantitative evaluation of large joint involvement in PsA and AS patients and allows for
treatment monitoring.
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Musculoskeletal ultrasound (US) is a valuable imaging tool
in rheumatic diseases and has been increasingly used in
rheumatologic practice and research in the last decade.
Compared with clinical examination, grey scale ultrasound
(GSUS) is a more sensitive method for detecting synovitis
and tenosynovitis. Therefore, several ultrasound scores,
mainly for RA, have been introduced recently to estimate
the inflammatory activity and the therapeutic response [1].
So far, mostly small joints such as the MCP-, PIP-, MTP-
joints and wrists were enrolled into the scanning proto-
cols, being the most affected joints in RA. However, also
large joints are frequently involved in the arthritic process
particularly in spondyloarthritis (SpA). Concerning
psoriatic arthritis (PsA), the majority of publications
have focused on entheseal inflammation, while surpris-
ingly few articles have reported on synovial inflammation
or hyperemia, which are characteristic features of large
joint involvement in this condition [2]. In ankylosing
spondylitis (AS) typically affecting the spine, the most fre-
quent single peripheral manifestation is peripheral arthritis
(46.6%), followed by enthesitis (9.8%) and dactylitis (1.9%)
[3]. GSUS and power Doppler ultrasound (PDUS) exhibit
a higher sensitivity in detecting inflammation of large
joints compared with clinical examination [4,5]. Despite
this fact, no US score for large joint involvement has been
yet developed for PsA and AS. Therefore, the main focus
of this project was the establishment of an US score for
large joints, as recently published by our group for
rheumatoid arthritis (RA) [6], in patients with PsA and
AS, suitable for daily rheumatologic practice.
Methods
A total of 126 patients suffering from PsA or AS and
presenting with arthritic manifestation of at least one
large joint underwent US examination. All PsA patients
had to fulfill the CASPAR criteria [7], while all AS patients
had to fulfill the ASAS classification criteria for spondy-
loarthritis in order to be included [8]. 83 of these patients
already concluded the 6 months visit. The clinically
dominant joint was evaluated sonographically after the
initiation of therapy, or escalation of the established
treatment.
Each patient gave his written informed consent for
participation of the study.
The study was approved by the ethics committee of
the University of Regensburg.
Clinical assessment
At baseline, and after 3 and 6 months, bilateral hips, el-
bows, shoulders and knees were clinically assessed for
swelling and tenderness. In addition, the following data
were recorded on report sheets: year of birth, sex, height,
weight, onset of typical symptoms, current rheumatologictherapy including DMARDs, biologics, and nonsteroidal
antiinflammatory drugs, as well as systemic and intraar-
ticular glucocorticoid dosage at each visit.Laboratory evaluation
Erythrocyte sedimentation rate (ESR, normal levels <
20 mm/hour) was obtained at each visit.US examination
As recently published for RA [6], the most affected large
joint was sonographically examined in a standardized modi-
fied manner according to the German [9] and European
League against Rheumatism (EULAR) [10] guidelines at
baseline and the follow up visits. All joint regions were
assessed by GSUS and PDUS.GSUS
Synovitis by GSUS was analyzed semiquantitatively
from 0 to 3 (0 = absence, 1 = mild, 2 = moderate, 3 = se-
vere, Table 1). Grade 1 represented a small abnormal
hypoechoic/anechoic line beneath the joint capsule.
For grade 2, the joint capsule is elevated parallel to the
joint area. Grade 3 characterizes a strong convex dis-
tension of the joint (Table 1).PDUS
PDUS was performed for synovitis and tenosynovitis
in each scanning plane. The semiquantitative findings
of PDUS activity for synovitis were scored as follows:
Grade 0 = no intraarticular color signal, grade 1 = up
to 3 color signals representing only low flow, grade 2 =
greater than grade 1 to < 50% of the intraarticular area
filled with color signals representing clear flow, grade
3 = > 50% of the intraarticular area filled with color
signals [1].
Based on these results, a score for each large joint
was established, including the sum of the synovitis
scores in the GSUS and the PDUS modes. Depending
on the number of scored planes, the score values are
different for the shoulder (GSUS/PDUS 0–6), the
elbow (GSUS/PDUS 0–9), the hip (GSUS/PDUS 0–3)
and the knee (GSUS 0–12 and PDUS 0–15). The max-
imum GSUS score of 12 for the knee is explained by
scanning four areas of the knee, the suprapatellar lon-
gitudinal, the medial longitudinal, the lateral longitu-
dinal, and the posterior region, each assigning a grade
from 0 to 3. In PDUS we scored the same areas of the
knee adding an additional infrapatellar longitudinal
scan and grading it from 0 to 3, yielding a total possible
score of 15.
Table 1 Overview of the sonographic regions scanned
Region Plane Grade 0 Grade 1 Grade 2 Grade 3
Shoulder Dorsal transverse Normal Effusion/synovitis in external rotation
only





Normal Joint capsule distension (JCD) concave JCD straight JCD convex
Elbow Humero-radial Normal JCD parallel to the humerus JCD straight JCD convex
Elbow Humerulnar Normal JCD paralel to the humerus JCD straight JCD convex




Normal JCD concave JCD straight JCD convex
Knee Suprapatellar
longitudinal
Normal JCD parallel to the humerus JCD straight JCD convex
Knee Medial/lateral
longitudinal
Normal JCD parallel to bone no distension
over the joint space
JCD parallel to bone distension
above the joint space
JCD convex above
the joint space
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The results regarding inter- and intrareader reliabil-
ity testing for the SOLAR-score have been recently
published [6].
Statistical analysis
Statistical analysis was performed with SPSS statistical
software, version 17.02 (SPSS, Chicago, IL). For quantita-
tive parameters (e.g., number of patients, age of examined
patients, and their disease activity), the mean and +/− SD
and range were determined. Significant changes were
calculated by the Wilcoxon Test. P-values less than 0.05
were considered statistically significant.
Results
Characteristics of patients
Eighty three patients (51.8% women) with a mean age of
45.3 ± 14.5 years were examined at three visits (baseline,Table 2 Ultrasound and laboratory results for the entire patie
US
Joint region US score/disease activity B
Shoulder (n = 11) GSUS (range 0–6)
PDUS (range 0–6)
Elbow (n = 10) GSUS (range 0–9)
PDUS (range 0–9)
Hip (n = 13) GSUS (range 0–3)
PDUS (range 0–3)
Knee (n = 49) GSUS (range 0–12)
PDUS (range 0–15)
ESR, mm/hour 2
#values represent the mean ± SD. US = ultrasound; GSUS = gray scale US; PDUS = poand following 3 and 6 months). 59% of patients suffered
from PsA and 41% from AS with peripheral joint in-
volvement present in all patients.Medication
At start of the observation, a total of 29% of the patients
received steroids (42% systemic administration, 6% sys-
temic and local intraarticular administration and 6%
local intraarticular injections into the target joint only).
Patients were treated with either DMARDs (49.4%) a
combination of DMARDs plus biologics (14.7%) or bio-
logic monotherapy (28.9%). A possible change in medi-
cation over the six months was not recorded.US and laboratory parameters
US, and laboratory results are depicted in Table 2 for the
entire group.nt group
and laboratory data (n = 83)#
aseline After 3 months After 6 months
2,8 ± 1.9 1,9 ± 1.5 1.1 ± 1.2*
1.7 ± 1.6 0,7 ± 1.0 0.4 ± 0.8*
4,3 ± 2.6 2.1 ± 1.9 0.9 ± 1.5*
2.3 ± 2.0 1.0 ± 1.2 0.6 ± 1.1*
2.0 ± 0.8 1.3 ± 0.8 1.0 ± 1.1*
0.7 ± 0.9 0.3 ± 0.5 0.3 ± 0.5
5.3 ± 2.9 3.5 ± 2.7 2.8 ± 2.8**
2.9 ± 3.1 1.5 ± 1.9 1.4 ± 2.4*
7.3 ± 22.6 18.0 ± 14.7 18.8 ± 16.1*
wer doppler US; ESR = erythrocyte sedimentation rate. *p < 0.05. **p < 0.001.
Schäfer et al. BMC Musculoskeletal Disorders 2013, 14:358 Page 4 of 5
http://www.biomedcentral.com/1471-2474/14/358Discussion
PsA and peripheral AS are sometimes considered as benign
forms of arthritis, however, these disease manifestations
affect patient’s quality of life substantially, and also cause
significant functional impairment [11].
Therefore, and considering the low sensitivity of clinical
assessment concerning inflammatory changes in large
joints, [5] the recently published US score for large joints
in RA patients has been applied in a cohort of PSA and
AS patients [12].
Two standardized scanning planes were defined for
the shoulder joint (the posterior transverse scan and the
axillary longitudinal scan). According to published data
and our own experience, these scanning planes allow for
detection of up to 95% of effusions/synovitis in the gleno-
humeral joint [13]. Furthermore, these two planes are easy
to perform and fast to apply.
The scanning protocol for the elbow covers the anterior
humeroradial, the anterior humeroulnar and the posterior
longitudinal scan over the olecranon fossa facilitating the
delineation of the joint capsule and pathologic distensions.
These planes have been successfully utilized for detection
of effusion and synovitis in the elbow joint [14].
The anterior longitudinal scan was chosen for the hip
to be the best for scoring of synovitis and hypervascu-
larisation as previously proposed by Boutry et al. [15].
In addition, a high correlation between histopathologically
confirmed vascularity and PDUS signal activity has been
demonstrated for the anterior longitudinal scan [16].
The knee was scanned in GSUS in four standardized
planes - the suprapatellar longitudinal, the medial longi-
tudinal, the lateral longitudinal, and the dorsal plane.
The infrapatellar longitudinal scan was additionally
added for the PDUS score, whereas only the suprapatel-
lar longitudinal scan and the medial and lateral recessus
have been analyzed in previous studies to estimate the
inflammatory activity.
Previously, the synovial thickness and power Doppler
flow have been measured in the suprapatellar and parapa-
tellar pouch, whereas the knee has been scanned in the
suprapatellar and parapatellar planes by other investiga-
tors [17]. According to our experience, the suprapatellar
and especially the medial and lateral longitudinal scans
are most suitable to detect hypervascularisation of an
inflamed knee joint, hence we chose these planes for
our protocol.
Utilizing the novel SOLAR score [12] for longitudinal
follow up of our PsA and AS cohort, a highly significant
reduction (p < 0.001) has been observed in GSUS scores
for the knee within 6 months of follow up. In addition,
PDUS and GSUS scores for for all joint areas improved
significantly (p < 0.05), with the only exception being the
PDUS of the hip. The decrease of systemic inflammation
as demonstrated by ESR reduction (p < 0.002) are reflectedin the SOLAR scores supporting the potential of this
scoring system to assess disease activity and monitor
treatment response of large joint involvement in PsA-
and AS patients.
A major limitation of the study is the lack of a “gold
standard” to adjust the ultrasound scoring. However, to
our knowledge, there have been no MRI scores developed
and published for arthritis in large joints, and conventional
x-ray scoring systems do not address soft tissue alter-
ations. Therefore, no other imaging modality could be ap-
plied to validate the results of the SOLAR score obtained
in PsA- and AS patients.
Conclusion
In conclusion, the SOLAR score is a valuable tool for
the US examination of inflamed large joints in patients
with PSA and AS. If large joints are affected, the SOLAR
score is a time-effective monitoring tool in daily rheum-
atological practice.
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